Literature DB >> 1981075

Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition.

A Groppelli1, S Omboni, G Parati, G Mancia.   

Abstract

In normotensive volunteers who habitually smoked more than 20 cigarettes a day, 1-h beat-to-beat blood pressure recordings were taken. Measurements were made using a non-invasive finger device when the subjects were not smoking (1 h, control) and during an hour in which the subjects were asked to smoke four cigarettes, one every 15 min. The first cigarette smoked produced a marked increase in systolic and diastolic blood pressures and the heart rate. The peak blood pressure and heart rate values observed for the first cigarette did not change when the remaining three cigarettes were smoked, indicating that the responses were neither attenuated nor increased by repeated smoking. However, after each cigarette, the pre-smoking values did not return to baseline, but were successively greater for the second, third and fourth cigarettes, indicating that blood pressure and the heart rate undergo a persistent increase during smoking. Compared with the hour-long non-smoking period, mean values over the smoking period were 18.8%, 14.0% and 29.7% higher for systolic and diastolic blood pressure and the heart rate, respectively. Cigarette smoking also increased the blood pressure and heart rate standard deviations around the mean, thereby increasing the variability. The effects of atenolol and doxazosin on the blood pressure and heart rate responses to smoking were investigated in two placebo-controlled, single-blind, randomly allocated, crossover studies. Compared with placebo, atenolol (50-100 mg given once a day for 4 days) significantly attenuated the smoking-induced increase in the heart rate but not the increase in systolic or diastolic blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981075

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  9 in total

1.  Effects of celiprolol on cardiovascular responses to smoking in normotensive smokers.

Authors:  R Fogari; G D Malamani; A Zoppi; P Lazzari; F Tettamanti; A Mugellini; L Corradi
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Relationship between physical activity/exercise habits and the frequency of new onset of lifestyle-related diseases after the Great East Japan Earthquake among residents in Fukushima: the Fukushima Health Management Survey.

Authors:  Fumikazu Hayashi; Tetsuya Ohira; Kanako Okazaki; Hironori Nakano; Akira Sakai; Mitsuaki Hosoya; Michio Shimabukuro; Atsushi Takahashi; Junichiro Kazama; Seiji Yasumura; Shigeatsu Hashimoto; Yukihiko Kawasaki; Gen Kobashi; Hitoshi Ohto; Kenji Kamiya
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

3.  Long-term cigarette smoking is associated with increased myocardial perfusion heterogeneity assessed by positron emission tomography.

Authors:  J G Meeder; P K Blanksma; E E van der Wall; R L Anthonio; A T Willemsen; J Pruim; W Vaalburg; K I Lie
Journal:  Eur J Nucl Med       Date:  1996-11

Review 4.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 5.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

Review 6.  Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.

Authors:  B Fulton; A J Wagstaff; E M Sorkin
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

7.  Distribution of risk factors of hypertension patients in different age groups in Tianjin.

Authors:  Yingyi Zhang; Hua Yang; Min Ren; Ruiying Wang; Fumei Zhao; Ting Liu; Ying Zhang; Zhigang Guo; Hongliang Cong
Journal:  BMC Public Health       Date:  2021-01-29       Impact factor: 3.295

8.  Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parameters.

Authors:  Aytekin Guven; Fatma Tolun
Journal:  Int J Med Sci       Date:  2012-10-25       Impact factor: 3.738

9.  Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates.

Authors:  Ginevra Biino; Gianfranco Parati; Maria Pina Concas; Mauro Adamo; Andrea Angius; Simona Vaccargiu; Mario Pirastu
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.